Citi downgrades Auxilium Pharmaceuticals Inc (Nasdaq: AUXL) from Buy to Hold. Price target lowered from $43 to $37.

This article: 135 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE